NASDAQ:EQ - Nasdaq - US29446K1060 - Common Stock - Currency: USD
Overall EQ gets a fundamental rating of 2 out of 10. We evaluated EQ against 556 industry peers in the Biotechnology industry. While EQ seems to be doing ok healthwise, there are quite some concerns on its profitability. EQ is valued expensive and it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -83.61% | ||
ROE | -132.23% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -15.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 2.7 | ||
Quick Ratio | 2.7 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
0.391
-0.02 (-5.58%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 0.46 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 1.32 | ||
P/tB | 1.32 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -83.61% | ||
ROE | -132.23% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 50.72% | ||
Cap/Sales | 0.23% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 2.7 | ||
Quick Ratio | 2.7 | ||
Altman-Z | -15.78 |